Extended Abstract

by John Maher, Lung-Ji Chang, John Quackenbush
Published 2016-05-01

CD19 and CD70 Dual-Target Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Relapsed and Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma

by Sanfang Tu, Xuan Zhou, Zhenling Guo, Rui Huang, Chunyan Yue, Yanjie He, Meifang Li, Yiran Chen, YuChen Liu, Lung-ji Chang, Lung-ji Chang, Lung-ji Chang, Yuhua Li
Published 2019-12-01

Successful Anti-CLL1 CAR T-Cell Therapy in Secondary Acute Myeloid Leukemia

by Hui Zhang, Wen-Ting Gan, Wen-Ge Hao, Peng-Fei Wang, Zhuo-Yan Li, Lung-Ji Chang, Lung-Ji Chang
Published 2020-05-01

Besides Increasing Surveillance and Waiting for an Effective Vaccine to Emerge in the Future, What Else Can Be Done to Save the Lives of HFMD Victims?

by Lung-Ji Chang, Luan-Yin Chang, Li-Min Huang
Published 2008-08-01

4SCAR‐GD2‐modified T‐cell therapy in neuroblastoma with MYCN amplification: A case report with over 4‐year follow‐up data

by Xiao Xu, Wen Zhao, Zhixia Yue, Maoquan Qin, Mei Jin, Lung‐Ji Chang, Xiaoli Ma
Published 2020-03-01

A Glimpse into the Diverse Cellular Immunity against SARS-CoV-2

by Cheng-Wei Chang, Yuchen Liu, Cheng Jiao, Hongwei Liu, Jie Gong, Xiaochuan Chen, Lung-Ji Chang
Published 2021-07-01

Bacterial delivery of nuclear proteins into pluripotent and differentiated cells.

by Candace Bichsel, Dennis K Neeld, Takashi Hamazaki, Donghai Wu, Lung-Ji Chang, Lijun Yang, Naohiro Terada, Shouguang Jin
Published 2011-01-01

Multilineage differentiation potential of hematoendothelial progenitors derived from human induced pluripotent stem cells

by Ratchapong Netsrithong, Siriwal Suwanpitak, Bootsakorn Boonkaew, Kongtana Trakarnsanga, Lung-Ji Chang, Chartsiam Tipgomut, Chinnavuth Vatanashevanopakorn, Kovit Pattanapanyasat, Methichit Wattanapanitch
Published 2020-11-01

Functional integration of human neural precursor cells in mouse cortex.

by Fu-Wen Zhou, Jeff M Fortin, Huan-Xin Chen, Hildabelis Martinez-Diaz, Lung-Ji Chang, Brent A Reynolds, Steven N Roper
Published 2015-01-01

Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

by Xuan Zhou, Sanfang Tu, Chunsheng Wang, Rui Huang, Lan Deng, Chaoyang Song, Chunyan Yue, Yanjie He, Jilong Yang, Zhao Liang, Anqin Wu, Meifang Li, Weijun Zhou, Jingwen Du, Zhenling Guo, Yongqian Li, Cheng Jiao, Yuchen Liu, Lung-Ji Chang, Lung-Ji Chang, Yuhua Li, Yuhua Li
Published 2020-11-01

GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma – assessing tumor and T cell interaction

by Jatuporn Sujjitjoon, Elias Sayour, Shih-Ting Tsao, Mongkol Uiprasertkul, Kleebsabai Sanpakit, Jassada Buaboonnam, Pa-thai Yenchitsomanus, La-ongsri Atchaneeyasakul, Lung-Ji Chang
Published 2021-02-01

4SCAR2.0: a multi-CAR-T therapy regimen for the treatment of relapsed/refractory B cell lymphomas

by Cheng Jiao, Eugene Zvonkov, Xun Lai, Rui Zhang, Yuchen Liu, Yue Qin, Valery Savchenko, Nelly Gabeeva, Tsai-Hua Chung, Liyuan Sheng, Lung-Ji Chang
Published 2021-03-01

Human antigen-specific regulatory T cells generated by T cell receptor gene transfer.

by Todd M Brusko, Richard C Koya, Shirley Zhu, Michael R Lee, Amy L Putnam, Stephanie A McClymont, Michael I Nishimura, Shuhong Han, Lung-Ji Chang, Mark A Atkinson, Antoni Ribas, Jeffrey A Bluestone
Published 2010-07-01

Could cytokine release syndrome induce acute myelofibrosis in CD19 chimeric antigen receptor T cells therapy?

by Xun Lai, Yun Yan Sun, Lung Ji Chang, Yu Ru Ma, Xue Zhong Gu, Xiang Mei Yao, Bo Nie, Yan Wen, Xue Mei Zhang, Ya Xian Jiang, Hui Yang, Li Qun Yu, Ming Jing Fang, Ling Wang, Xue Yuan Bo
Published 2020-01-01